We Are Equestrians
Found this posted on Facebook. The video is amazing. I did some searching and found the original artist, sophianinam on YouTube, who created this video:
Similar Posts
Isis as a yearling
Here is a video of Isis (bay) and her sister Asiirah (chestnut) when they were yearlings. Hard to believe Isis will be 17 this year. Funny how her blaze took up her entire face as a youngster and how she grew into it. Related Images:
Chronicles
I’ve always been a writer, and it’s always made sense to me to deal with issues by writing. I was reading through old posts on here and discovered just how much I’ve captured of Isis’ saga on this blog. Same with Basette and Ambush, my old kitties. A friend here at work suggested pulling Isis’…
Walking out with Isis
The Bay Wonder Mare is showing her amazing recovery powers again. She’s picking up her toes and moving out with style. It’s amazing that she’s been on the Oroquin-10 for a week and she is already almost back to normal. Some of the people at the barn have commented that Isis looks like she has…
oOoo a sale!
Triangle Horse Sports is having a sale this weekend. Not just any sale, but a Stubben bridle for $50 type of sale. (These bridles normally run $200-$500.) None of the bridles were the right size for my mares. I found one, but after careful thinking (and much “but it’s a Stubben!” reasoning), I ended up…
Miracle Mare: Above and Beyond
A friend of mine is working on a book and had asked me if there were any situations I’d like to share where my horse had gone above and beyond what might normally be expected. My initial reaction was ‘Where do I start?’ I have lost almost half of Isis’s available riding time to medical…
EPM study by Pathogenes with Oroquin-10
Pathogenes, a company in Florida specializing in treatments and diagnostic tools for EPM, is sponsoring a study of Oroquin-10, a new treatment for EPM. It’s not a double-blind study, however the company, Pathogenes, has a protocol they are asking owners to follow. Here are the links I sent my vet for the clinical trial for…